Related Experiment Video
Updated: May 7, 2026

Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization
Published on: June 7, 2016
miRNA in mycosis fungoides and skin inflammation
1Division of Experimental Cancer Research, Department of Laboratory Medicine, Lund University, Clinical Research Center, Malmö, Sweden.
Abstract:
In this mini-review, progress in our understanding of the link between miRNAs and cytokines in inflammatory skin diseases is highlighted with focus on miR-155 in mycosis fungoides (MF). MF is the most common variant of cutaneous T-cell lymphoma (CTCL) and is characterized by malignant T-cell proliferation in a chronic inflammatory environment in affected skin. Recent data show that miR-155 is expressed in situ by both malignant and non-malignant T cells, induced via the STAT5 signal pathway and IL-2Rbeta/gamma cytokines, and thus suggest the importance of miR-155 in malignant proliferation, clinical diagnosis, and prognosis in CTCL.
Related Concept Videos
MicroRNAs
Abnormal Proliferation
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

